- RecruitingPHASE2
Methods of T Cell Depletion Trial (MoTD)
This study compares different ways to prevent a complication called GvHD after stem cell transplants for various blood cancers. It's looking for the best treatment plan to help patients recover well, using common medicines like Thymoglobulin, Cyclophosphamide, Cyclosporine, Sirolimus, and Mycophenolate Mofetil.
For: Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia · Chronic Myelomonocytic LeukemiaUnited Kingdom - Active not recruitingPHASE1, PHASE2
Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)
This study is testing a new treatment, LY3884961, for babies with a serious inherited condition called Type 2 Gaucher disease. Researchers want to see if it's safe and effective. It's a long-term study, following babies for up to 5 years.
For: Gaucher Disease, Type 2United States · United Kingdom - AuthorisedTherapeutic use (Phase IV)
Safety and efficacy of steering of immunosuppression based on BKPyV-specific T cells in case of BK Polyomavirus (BKPyV) DNAe- mia after kidney transplantation
This study looks at how well a new approach to adjusting medicines helps control a common virus called BK Polyomavirus (BKPyV) in people who have had a kidney transplant. The goal is to find the best way to keep the new kidney healthy.
For: BK Polyomavirus DNAemia after kidney transplantationGermany